Doyle I R, Barr H A, Nicholas T E
Department of Human Physiology, School of Medicine, Flinders University of South Australia, Adelaide.
Am J Respir Cell Mol Biol. 1994 Oct;11(4):405-15. doi: 10.1165/ajrcmb.11.4.7917309.
Although surfactant protein A (SP-A) is an integral component of alveolar surfactant, its relative abundance in lamellar bodies, regarded as the intracellular storage organelles for surfactant, remains contentious. We have previously shown that lamellar bodies, isolated from rat lung by upward flotation on a sucrose gradient, can be subfractionated into classic-appearing lamellar bodies (Lb-A) and a vesicular fraction (Lb-B), which we have speculated may be a second release form of surfactant. In the present study, we have used two-dimensional protein electrophoresis and immunochemical analysis to clarify the origin and the composition of these two subcellular fractions. In addition, we have examined the hypothesis that the secretion of SP-A and surfactant phospholipids occurs by independent pathways by examining the distribution of SP-A, total protein, and disaturated phospholipids (DSP) in the tubular myelin-rich (Alv-1) and tubular myelin-poor (Alv-2) fractions separated from lavaged material and in Lb-A and Lb-B isolated from both lung homogenate and purified alveolar type II cells. Our findings indicate that Lb-B is derived from type II cells, although they do not indicate whether it is a secretory form of surfactant, a reuptake vesicle, or a mixture of both. We found that the lung has a large tissue pool of immunoreactive SP-A. The %SP-A/DSP of total lamellar bodies isolated from type II cells was 0.96 +/- 0.1 (mean +/- SE), intermediate between that in Lb-A (1.67 +/- 0.13) and in Lb-B (0.65 +/- 0.04). In contrast, the %SP-A/DSP was 11.16 +/- 0.84 in whole lung homogenate and 13.14 +/- 1.71 in whole type II cells. In the alveolar compartment, the %SP-A/DSP was 17.38 +/- 3.40 in Alv-1, 6.34 +/- 0.31 in Alv-2, and 10.49 +/- 1.43 in macrophages, values an order of magnitude greater than found with the lamellar bodies. Our results indicate that only a relatively small portion of alveolar SP-A is derived from lamellar bodies, and we suggest that secretion of SP-A and DSP occurs via independent pathways.
尽管表面活性蛋白A(SP-A)是肺泡表面活性剂的一个组成部分,但其在板层小体(被视为表面活性剂的细胞内储存细胞器)中的相对丰度仍存在争议。我们之前已经表明,通过在蔗糖梯度上向上漂浮从大鼠肺中分离出的板层小体,可以进一步亚分级为外观典型的板层小体(Lb-A)和囊泡部分(Lb-B),我们推测后者可能是表面活性剂的第二种释放形式。在本研究中,我们使用二维蛋白质电泳和免疫化学分析来阐明这两个亚细胞部分的起源和组成。此外,我们通过检查从灌洗材料中分离出的富含管状髓磷脂的部分(Alv-1)和管状髓磷脂含量低的部分(Alv-2)以及从肺匀浆和纯化的肺泡II型细胞中分离出的Lb-A和Lb-B中SP-A、总蛋白和二饱和磷脂(DSP)的分布,检验了SP-A和表面活性剂磷脂通过独立途径分泌的假说。我们的研究结果表明,Lb-B来源于II型细胞,尽管它们并未表明其是否为表面活性剂的分泌形式、再摄取囊泡或两者的混合物。我们发现肺中有大量具有免疫反应性的SP-A组织池。从II型细胞分离出的总板层小体的SP-A/DSP百分比为0.96±0.1(平均值±标准误),介于Lb-A(1.67±0.13)和Lb-B(0.65±0.04)之间。相比之下,全肺匀浆中的SP-A/DSP百分比为11.16±0.84,全II型细胞中的为13.14±1.71。在肺泡隔中,Alv-1中的SP-A/DSP百分比为17.38±3.40,Alv-2中的为6.34±0.31,巨噬细胞中的为10.49±1.43,这些值比板层小体中的大一个数量级。我们的结果表明,肺泡SP-A中只有相对较小的一部分来源于板层小体,并且我们认为SP-A和DSP的分泌是通过独立途径进行的。